The Role of Irreversible EGFR Inhibitors in the Treatment of Non-Small Cell Lung Cancer: Overcoming Resistance to Reversible EGFR Inhibitors

By Belani Chandra P.  

Cancer Investigation, Vol. 28, Iss. 4, 2010-04 ,pp. : 413-423

Informa Healthcare

Access to resources Recommend Favorite

HER-2, EGFR, COX-2 Expression status correlated to microvessel density and survival in resected non-small cell lung cancer

By Brattström Daniel   Wester Kenneth   Bergqvist Michael   Hesselius Patrik   Malmström Per-Uno   Nordgren Hans   Wagenius Gunnar   Brodin Ola  

Acta Oncologica, Vol. 43, Iss. 1, 2004-03 ,pp. : 80-86

Informa Healthcare

Access to resources Recommend Favorite

Impact of EGFR Inhibitor in Non-Small Cell Lung Cancer on Progression-Free and Overall Survival: A Meta-Analysis

By Lee Chee Khoon   Brown Chris   Gralla Richard J.   Hirsh Vera   Thongprasert Sumitra   Tsai Chun-Ming   Tan Eng Huat   Ho James Chung-Man   Chu Da Tong   Zaatar Adel   Osorio Sanchez Jemela Anne   Vu Vu Van   Au Joseph Siu Kie   Inoue Akira   Lee Siow Ming   Gebski Val   Yang James Chih-Hsin  

Journal of the National Cancer Institute, Vol. 105, Iss. 9, 2013-05 ,pp. : 595-605

Oxford University Press

Access to resources Recommend Favorite

Usefulness of plasma HGF level for monitoring acquired resistance to EGFR tyrosine kinase inhibitors in non-small cell lung cancer

By  

Oncology Reports, Vol. 33, Iss. 1, 2015-01 ,pp. : 391-396

Spandidos Publications

Access to resources Recommend Favorite

The impact and role of EGFR gene mutation on non-small cell lung cancer

By Toyooka Shinichi   Soh Junichi   Shigematsu Hisayuki   Aoe Motoi   Date Hiroshi  

Cancer Chemotherapy and Pharmacology, Vol. 58, Iss. 7, 2006-11 ,pp. : 25-31

Springer Publishing Company

Access to resources Recommend Favorite